A blood test that accurately detects colon cancer in middle-aged and older people and also rules it out when it is not present can help to increase the rate of screening for the disease in the U.S.

A second blood test shows promise for the detection of colon cancer, according to a new study. The first, called Shield, was approved by the Food and Drug Administration in July for people 45 and ...

Kentucky has one of the highest rates of colorectal cancer in the US, but early detection leads to a 91% five-year survival rate. Colorectal cancer is projected to become the leading cancer killer for ...

Liquid biopsies have transformed cancer testing. These tests detect signs of cancer using a simple blood draw instead of removing tissue from the body. Traditional biopsies involve surgery, needles, ...

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer, NBC News reported. The test isn't meant to replace colonoscopies, but is ...

In 2024, the Food and Drug Administration (FDA) approved a blood test that can screen for colorectal cancer in people older than 45 years old at average risk for the disease. Some people may skip ...

AUSTIN (KXAN) – There is a new and less invasive option to test for colon cancer and it doesn’t require a stay at the hospital or mailing a stool sample. The Food Drug and Administration approved ...

A new way to screen for colon cancer is giving Americans more options to spot the disease in its early stages. According to the American Cancer Society, 1-in-3 adults do not get screened as ...

Scientists are developing a less invasive portable device that would use blood samples to detect colorectal cancers. No one looks forward to a colonoscopy. The procedure, which is used to screen for ...

ctDNA testing post-surgery identifies high-risk stage 3 colon cancer patients more accurately than traditional staging methods. Detectable ctDNA correlates with a four- to six-fold increased risk of ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham Cancer Center found that patients with evidence of residual cancer in their ...

Colon cancer is hitting long before the usual screening age. If you could ID who's at risk, you could screen early and save ...